No summons during grace period for medicine price display
Health deputy director-general (Pharmaceutical Services) Dr Azuana Ramli said the Price Control and Anti-Profiteering (Price Labelling for Medicines) Order 2025, which came into force on May 1, would initially focus on educational aspects to ensure all stakeholders understand the new requirements.
'During these three months, there are no plans to issue any summons. This phase is focused on advocacy and monitoring how the implementation is being carried out,' she said at a briefing session on the Medicine Price Display initiative here today.
Also present was Domestic Trade and Cost of Living Ministry (KPDN) Enforcement director-general Datuk Azman Adam.
Under the order, all private healthcare facilities and community pharmacies must display clear price labels for medicines, either on shelves, in catalogues or in written price lists.
Azuana said that during these three months, monitoring would be led by the MOH's Pharmaceutical Services Division, supported by KPDN enforcement officers.
Asked whether the initiative constitutes price control, she clarified that it aims to enhance price transparency under the Price Control and Anti-Profiteering Act 2011, and not about controlling medicine prices.
Meanwhile, Azman refuted claims by a private doctors' group that KPDN officers issued three-day warning notices to clinics yesterday.
He explained that the enforcement team was in the area for inspections related to cooking gas and egg supplies, and happened to ask a clinic staff member about the implementation of the price display rule.
'No notices or summonses were issued,' he said.
Asked about the possibility of price manipulation in response to the regulation, Azman expressed confidence in the industry's maturity.
The medicine price display initiative aims to enhance price transparency, protect consumer and patient rights, improve the quality of healthcare services, promote healthy industry competition, and support informed decision-making by consumers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 hours ago
- The Star
Singapore's ministry of health studying 18 proposals to integrate TCM into public healthcare
SINGAPORE: The use of acupuncture to treat migraines, for post-stroke rehabilitation and cancer-related care could soon be integrated into the national healthcare system under a sandbox initiative. These are among 18 proposals for evidence-based traditional Chinese medicine (TCM) treatments that the authorities are evaluating under a TCM sandbox initiative, Health Minister Ong Ye Kung said on Sunday (July 6). The other TCM treatments that the three healthcare clusters here have proposed for the sandbox include the use of Chinese medicine for treating gastrointestinal disorders and chronic pain, alongside conventional treatments. If implemented in public clinics and hospitals, these treatments could become eligible for subsidies and MediSave coverage, which today apply to two TCM treatments: the use of acupuncture for lower back and neck pain. Speaking at a forum on the use of evidence-based TCM in Western medicine practice, Ong said the latest move follows from his announcement in October 2024 that the Ministry of Health (MOH) was evaluating the efficacy of other TCM therapies beyond those two treatments. He emphasised that this was not about wholesale adoption of TCM treatments, but a thoughtful selection of therapies that have been shown to work, complementing Western medicine to improve outcomes for patients, including those who do not respond well to conventional treatments alone. As a start, these proposed treatments will be evaluated for scientific robustness by an MOH-commissioned committee, and then trialled 'in a controlled environment' in public healthcare institutions for one to two years. 'During the sandbox phase, our foremost priority is to ensure patient safety and maintain high standards of care,' Ong said. 'The evaluation will also enable us to assess the cost-effectiveness of these treatments.' He noted that TCM is already an integral part of Singapore's healthcare landscape, with one in five adult Singaporeans relying on TCM services each year, according to the 2022 National Population Health Survey. 'Our vision is not simply adding more TCM services to hospital settings, but to create a really integrative care model where the strengths of both systems can be leveraged for optimal patient care,' he added. At the forum, Ong also announced that from 2026, an annual national-level award jointly launched by MOH and the Academy of Chinese Medicine Singapore will recognise exemplary TCM practitioners. There will be two categories of awards – one for outstanding physicians and another for outstanding educators – and recipients will be awarded a cash amount of $5,000 each. Nominees for the awards must be Singaporeans or permanent residents currently practising here, with at least 15 years of experience. The forum – organised by SingHealth and the academy – was attended by about 420 people, most of whom were doctors and TCM physicians. Addressing attendees, National Neuroscience Institute senior neurological consultant Lim Shih Hui said the forum, which he co-chaired, would help foster a common language between these practitioners to bridge diagnoses in Western medicine and TCM. By integrating evidence-based traditional and Western medicine practices, the healthcare system can empower patients to make better-informed decisions and benefit from the strengths of both medical systems, he added. Speaking to reporters, Professor Lim noted that SingHealth has been looking to improve treatment for conditions and diseases that Western medicine struggles to tackle, owing to limitations or the lack of data. He said the public health cluster, the largest here, submitted more than half of the proposals to incorporate TCM for treatment of conditions such as migraine, epilepsy and other disorders. 'Migraine is a very common thing, but medication for migraines, though effective, has side effects,' he said. 'So if we can use TCM treatment to complement Western treatment, the patient will have good effects as well as fewer side effects.' SingHealth deputy group chief executive for medical and clinical services Fong Kok Yong told forum participants that integration of TCM will be contingent on extensive clinical research. To this end, he suggested that all publicly funded TCM research grants favour collaboration between the healthcare clusters. He said: 'The larger the cohort being studied, the more robust is the clinical evidence, and I firmly believe that TCM trials that involve all three (public health) clusters and relevant TCM partners are best placed to provide such robust evidence.' President of the Academy of Chinese Medicine Singapore Goh Kia Seng, who co-chaired the forum, told the media in Mandarin that he welcomed the launch of the first national-level award for TCM practitioners, of which there are more than 3,200 here. 'This is a sign that the Health Ministry and the country have begun to attach importance to being a TCM practitioner, sending an important message to those in the profession here,' said Dr Goh. The latest announcements add to the Government's hope for TCM – which seeks to maintain balance between the body's systems and the outside environment – to play a bigger role in public health. In October 2024, Ong said TCM practitioners may in future partner general practitioners under an expanded Healthier SG programme. Worldwide, the integration of TCM has already reaped benefits for Western medicine, Beijing University of Chinese Medicine's Professor Liu Jianping told attendees. The founder of the university's Centre for Evidence-Based Chinese Medicine cited the therapeutic benefit of sweet wormwood, a herb in TCM that has been recognised for its ability to treat the life-threatening disease of malaria. In 2015, China received its first Nobel Prize in medicine for a therapy developed from the herb, which has saved millions of lives across the globe. - The Straits Times/ANN
Daily Express
11 hours ago
- Daily Express
Costly private or over-burdened govt hosps?
Published on: Sunday, July 06, 2025 Published on: Sun, Jul 06, 2025 By: Lee Ke Yin, Tee Chen Giap Text Size: RECENTLY, Malaysians have been bombarded with headlines about rising medical costs, forcing many to either pay up, or forgo private healthcare, and turn to the 'near-collapsed' public healthcare system. Both are undesirable options. Meanwhile, across the globe, just a few months ago, Luigi Mangione, in a moment of rage and desperation, pulled the trigger on Brian Thompson, the CEO of a major US health insurance company. Advertisement The impact of the gunshots that were fired in New York still continue to ripple throughout the world. To some, it was an act of senseless violence. To others, it was the breaking point for a man who saw himself as a victim of a healthcare system that decides who gets to live and who doesn't. While Malaysia's healthcare system differs significantly from that of the US, we are similarly facing a dire healthcare crisis: Malaysians find themselves trapped between unaffordable private care and an overstretched public system struggling to provide essential services. As our country navigates this two-pronged healthcare crisis, what can be done before it collapses and creates our own Luigi Mangione? Generally, healthcare systems follow either the Bismarck model, developed by Otto von Bismarck, Germany's first chancellor, or the Beveridge model, developed by William Beveridge, a British economist-politician. The Bismarck model was adopted to build healthcare funded by private insurance and employers, as reflected in the US, while the Beveridge model gave birth to the taxpayer-funded National Health Service in the UK, which the Ministry of Health Malaysia (MoH) system is based on. However, as demand for healthcare grew, private hospitals, health insurance schemes and employer-sponsored medical benefits rapidly sprouted in the country. This was how the two-tiered healthcare system started in Malaysia: A taxpayer-funded public healthcare system and a market-driven, predominantly insurance-based private healthcare system. The key difference between the US' and Malaysia's healthcare systems is that while Malaysians can always rely on the 'safety net' of taxpayer-funded public healthcare, Americans do not have this 'privilege'. This prompts a crucial question: Is healthcare a fundamental human right, or is it merely a privilege dictated by power and economic forces? Malaysians know very well that our public healthcare system has long been overstrained. It suffers from overcrowding and extremely long waiting times. In some government hospitals, it is not unknown for patients in emergency departments to experience waiting times of over 24 hours before being admitted. The bed occupancy rate (BOR) in some hospitals has even surpassed 100pc, leading to the use of makeshift beds in corridors. Furthermore, the pressure on doctors and nurses is evident from the newspaper headlines that range from 'Malaysia's medical graduates glut' to 'It's back to a shortage of doctors', the contract doctors' strike (Hartal Doktor Kontrak), and the recent government mandate for longer working hours for government staff nurses. This issue is exacerbated by the low level of public healthcare spending, where the latest regional data in 2021 shows that it amounts to only 4.38pc of Malaysia's gross domestic product — significantly lower than our neighbours (Thailand 5.16pc, the Philippines 5.87pc, Singapore 5.57pc) and well below the spending level seen in developed countries (more than 10pc of GDP). While Malaysians often pride themselves on the 'cost effectiveness' of our healthcare system, it comes at the price of quality healthcare delivery due to a long-standing mismatch between supply and demand. All of this leads to poorer health outcomes for Malaysians, from delays in receiving crucial treatment to constraints in accessing more effective (but costly) treatment options. Till today, discussions among stakeholders have largely focused on public health, and the legal and economic aspects of the healthcare crisis. A crucial, fresh perspective needs to be introduced to the discussion table. As healthcare decisions and policies are enacted that benefit particular stakeholders while depriving others, these should be viewed as active exercises of 'biopower'. The term 'biopower' was popularised by an influential French historian and philosopher, Michel Foucault, in the mid-20th century. It refers to the state and institutions actively regulating lives, health, reproduction and mortality, with the ultimate goal of managing populations. In modern societies, power is no longer limited to traditional sovereign control, as it can manifest in more subtle mechanisms such as policies, health normalisation and surveillance — ultimately deciding who lives and dies within a population. In other words, it has shifted from a 'power to take life [away]' to a 'power over life', or rather, a power to 'help live and let die'. The state actively controls resource allocation and determines the standard of healthcare accessible to the population, shaping health outcomes through policy decisions. It has sadly become 'normal' for Malaysians to suffer complications of diabetes, such as heart disease, cancers, and including amputations, despite these being largely preventable especially when benchmarked against other nations. When diagnosed with diabetes, Malaysians often do not feel an urgency to regain control of their health due to the 'norm' set by current policies, budgets and healthcare standards — a downwards spiralling continuum. The fact that Malaysia is the most obese country in Southeast Asia — due to lifestyle, food and health literacy factors, all of which are influenced by policies through biopower — makes it even less surprising that we have the highest prevalence of diabetes in Asean. This forces us to confront a difficult reality: Who is being left behind or, to use the words of Foucault, 'to let die', in the pursuit of economic efficiency? On the other hand, in private healthcare, healthcare costs are skyrocketing, as seen in University Malaya Medical Centre's medical fees surging by over 200pc, to insurance companies reportedly intending to increase healthcare premiums by up to 70pc this year, until regulators intervened. While the existence of a two-tier system offers more options for Malaysians seeking medical treatment, many such treatments remain out of reach: Only 22pc of Malaysians are insured by personal medical insurance. More worryingly, a stark number of Malaysians are going bankrupt due to healthcare expenditure. Out of 8,321 debt default cases solved by the Credit Counselling and Debt Management Agency (AKPK) in 2015, some 14.3pc was due to high medical costs. The rapid rise in medical inflation will drive more Malaysians away from private healthcare, while further overwhelming the already strained public healthcare. At face value, the decision by faceless bureaucrats to hike medical fees can always be justified through economic reasoning. However, we must critically examine how the decisions of these institutions, even when driven by economic logic, can profoundly shape the lives of Malaysians. The framing of healthcare as a mere commodity — subject to market forces and investor returns — should be challenged, especially when discussions reduce it to a numbers game. Political philosopher Michael J Sandel's words are especially relevant: 'We cannot actually put a monetary value on human life ... to do so is to treat lives as commodities rather than as beings worthy of respect and dignity.' As healthcare costs continue to rise under the guise of economic necessity, we must first recognise this as an expression of biopower, where systemic policies and economic forces end up shaping who gets to live well and who is left behind. Observing the healthcare systems via the lens of biopower offers two major benefits: First, biopower reveals that healthcare is never neutral; it is shaped by policies that can reflect political agenda. Next, acknowledging this fosters crucial discussions surrounding healthcare injustices, and reinforces healthcare as a fundamental human right for all. Recent developments, including stakeholder engagements and public hearings by the Public Accounts Committee, mark a crucial step forward in fostering inclusive polylogue on healthcare costs. These discussions facilitate a comprehensive review of hospital charges and insurance premiums. Bank Negara Malaysia's decision to impose a 10pc cap on insurance premium hikes reflects an institutional willingness to balance economic considerations with public welfare. While efforts are made to evaluate inefficiencies and unjustified pricing distortions, the rakyat must exercise democracy themselves by actively participating in town halls and public hearings. This collective effort helps to hold leaders and policymakers accountable, serving as a counterbalance to the structural power that shapes healthcare outcomes in society. The Malaysian Philosophy Society urges the government to prioritise healthcare budget allocations to bring transformative changes to the public healthcare system. The long-held notion of national pride in a 'low cost and efficient' public healthcare model is no longer sustainable, as the widening cracks in the system make evident. To meet the growing healthcare needs of the population, proactive investments and systemic reforms are imperative. Apart from that, we echo the call for transparent pricing methodologies and ethical costing models used in healthcare to curb the exponential rate of medical inflation due to predatory practices. Ignoring these realities risks abandoning more lives from both fronts of healthcare sectors and recreating our very own Mangione in Malaysia. Lee Ke Yin is a content curator at the Malaysian Philosophy Society and a student at University Malaya. Dr Tee Chen Giap is a medical doctor and co-founder of the Malaysian Philosophy Society. The views expressed here are the views of the writer and do not necessarily reflect those of the Daily Express. If you have something to share, write to us at: [email protected]
The Sun
14 hours ago
- The Sun
‘Use of EPF Account 2 for health insurance voluntary'
PUTRAJAYA: Using the Employees Provident Fund (EPF) Account 2 for the government Medical and Health Insurance Takaful scheme is entirely voluntary, said Health Minister Datuk Seri Dr Dzulkefly Ahmad. 'Even the basic medical health insurance takaful itself is not compulsory,' he said at a media conference at the national-level World Food Safety Day 2025 celebration yesterday. Dzulkefly said Malaysians who choose to purchase the coverage could do so either through out-of-pocket payments or using funds from Account 2. 'It is a voluntary product. This is not like the National Health Insurance scheme proposed in the past. There is no compulsion.' The scheme, developed jointly by the Health Ministry, Finance Ministry and insurers, aims to offer affordable basic protection options to the public. Contributors had raised concern that the use of EPF savings for insurance might deplete their retirement funds. On a separate matter, Dzulkefly revealed that Malaysia recorded 204 food poisoning cases between January and May, compared with 707 cases in 2024, a 23% decline. He emphasised the need for continued vigilance. 'I want to do better. I am never complacent.' Themed 'Food Safety: Science in Action', the event held at the Alamanda Shopping Centre in Putrajaya saw simultaneous programmes carried out in five states, namely Johor, Selangor, Penang, Sabah and Sarawak. Dzulkefly said food safety must become an everyday priority and not just a seasonal campaign. He urged the public to take responsibility through simple practices such as inspecting food labels, ensuring proper storage and applying the 'look, smell and taste' approach before eating anything. 'Food safety begins with us. We are the first checkpoint.' He also highlighted the economic burden of non-communicable diseases, citing an estimated RM64.3 billion in annual direct and indirect costs to manage illnesses such as cancer, heart disease, diabetes and hypertension. 'We will never be able to build enough hospitals to manage the sick if we fail to prioritise prevention.' On the enforcement of the smoking ban at eateries, Health Deputy Director-General (Public Health) Dr Ismuni Bohari said smoking remains prohibited within three metres of any area at which food is served, even if tables and chairs are placed outside the formal premises. He said local authorities are responsible for licensing the physical layout of food outlets, but the smoking restriction is enforced under the Control of Tobacco Product Regulations. 'We want to protect the public from exposure to second-hand smoke, especially in dining areas.'
